Cardioprotection with forsythoside B in rat myocardial ischemia-reperfusion injury: Relation to inflammation response

Phytomedicine

Volumn 17, Issue 8-9, 2010, Pages 635-639

  Jiang, W L ^a,b   Fu, F H ^a   Xu, B M ^a   Tian, J W ^a   Zhu, H B ^b   Jian Hou, ^b  

^a YANTAI UNIVERSITY   (China)

^b Shandong Engineering Research Center for Nature Drug   (China)

Author keywords

Forsythoside B; Hemodynamics; High mobility group box 1; Inflammation response; Ischemia reperfusion; Troponin T

Indexed keywords

FORSYTHOSIDE B; GLUTATHIONE PEROXIDASE; HIGH MOBILITY GROUP B1 PROTEIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MALONALDEHYDE; MYELOPEROXIDASE; PLANT MEDICINAL PRODUCT; SUPEROXIDE DISMUTASE; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; HEART FUNCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE DP-DT; HEART MUSCLE INJURY; HEART PROTECTION; HISTOPATHOLOGY; INFLAMMATION; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SYSTOLIC BLOOD PRESSURE; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; GLYCOSIDES; HEART; HEMODYNAMICS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LAMIACEAE; LEUKOCYTES; MALE; MALONDIALDEHYDE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PEROXIDASE; PHYTOTHERAPY; RATS; RATS, SPRAGUE-DAWLEY; TROPONIN T; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 77952289119     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2009.10.017     Document Type: Article

References (30)

1. Abe M., Takiguchi Y., Ichimaru S., Kaji S., Tsuchiya K., and Wada K. Different effect of acute treatment with rosiglitazone on rat myocardial ischemia/reperfusion injury by administration method. Eur. J. Pharmacol. 589 (2008) 215-219
2. Andrassy M., Volz H.C., Igwe J.C., Funke B., Eichberger S.N., Kaya Z., et al. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 117 (2008) 3216-3226
3. Basaga H.S. Biochemical aspects of free radicals. Biochem. Cell Biol. 68 (1990) 989-998
4. Bradley P.P., Christensen R.D., and Rothstein G. Cellular and extracellular myeloperoxidase in pyogenic inflammation. J. Invest. Dermatol. 78 (1982) 206-209
5. Cuzzocrea S., Costantino G., Mazzon E., Micali A., De-Sarro A., and Caputi A.P. Beneficial effects of melatonin in a rat model of splanchnic artery occlusion and reperfusion. J. Pineal. Res. 28 (2000) 52-63
6. Delazar A., Sabzevari A., Mojarrab M., Nazemiyeh H., Esnaashari S., Nahar L., Razavi S.M., and Sarker S.D. Free-radical-scavenging principles from Phlomis caucasica. Nat. Med. (Tokyo) 62 (2008) 464-466
7. Entman M.L., Michael L.H., Rossen R.D., Dreyer W.J., Anderson D.C., Taylor A.A., and Smith C.W. Infl{ligature}ammation in the course of early myocardial ischemia. FASEB J. 5 (1991) 2529-2537
8. Fiuza C., Bustin M., Talwar S., Tropea M., Gerstenberger E., Shelhamer J.H., and Suffredini A.F. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 101 (2003) 2652-2660
9. Haider K.H., and Stimson W.H. Cardiac myofibrillar proteins: biochemical markers to estimate myocardial injury. Mol. Cell. Biochem. 194 (1999) 31-39
10. Hoffmeyer M.R., Scalia R., Ross C.R., Jones S.P., and Lefer D.J. PR-39, a potent neutrophil inhibitor attenuates myocardial ischemia-reperfusion injury in mice. Am. J. Physiol. Heart Circ. Physiol. 279 (2000) H2824-2828
11. Hu, X., Jiang, H., Cui, B., Xu, C., Lu, Z., He, B. Preconditioning with high mobility group box 1 protein protects against myocardial ischemia-reperfusion injury. Int. J. Cardiol., ahead of print.
12. Ismailoglu U.B., Saracoglu I., Harput U.S., and Sahin-Erdemli I. Effects of phenylpropanoid and iridoid glycosides on free radical-induced impairment of endothelium-dependent relaxation in rat aortic rings. J. Ethnopharmacol. 79 (2002) 193-197
13. Kawano S., Kubota T., Monden Y., Tsutsumi T., Inoue T., Kawamura N., Tsutsui H., and Sunagawa K. Blockade of NF-kappaB improves cardiac function and survival after myocardial infarction. Am. J. Physiol. Heart. Circ. Physiol. 2 291 (2006) H1337-1338
14. Kim J.W., Jin Y.C., Kim Y.M., Rhie S., Kim H.J., Seo H.G., Lee J.H., Ha Y.L., and Chang K.C. Daidzein administration in vivo reduces myocardial injury in a rat ischemia/reperfusion model by inhibiting NF-κB activation. Life Sci. 84 (2009) 227-234
15. Lotze M.T., and Tracey K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5 (2005) 331-342
16. Martin-Nizard F., Sahpaz S., Furman C., Fruchart J.C., Duriez P., and Bailleul F. Natural phenylpropanoids protect endothelial cells against oxidized LDL-induced cytotoxicity. Planta Med. 69 (2003) 207-211
17. Martin-Nizard F., Sahpaz S., Kandoussi A., Carpentier M., Fruchart J.C., Duriez P., and Bailleul F. Natural phenylpropanoids inhibit lipoprotein-induced endothelin-1 secretion by endothelial cells. J. Pharm. Pharmacol. 56 (2004) 1607-1611
18. Nazemiyeh H., Rahman M.M., Gibbons S., Nahar L., Delazar A., Ghahramani M.A., Talebpour A.H., and Sarker S.D. Assessment of the antibacterial activity of phenylethanoid glycosides from Phlomis lanceolata against multiple-drug-resistant strains of Staphylococcus aureus. Nat. Med. 62 (2008) 91-95
19. Sagach V.F., Scrosati M., Fielding J., Rossoni G., Galli C., and Visioli F. The water-soluble vitamin E analogue Trolox protects against ischemia/reperfusion damage in vitro and ex vivo. A comparision with vitamin E. Pharmacol. Res. 45 (2002) 435-439
20. Sahpaz S., Garbacki N., Tits M., and Bailleul F. Isolation and pharmacological activity of phenylpropanoid esters from Marrubium vulgare. J. Ethnopharmacol. 79 (2002) 389-392
21. Shandeyla S.M.L., Kuppusamy P., Weisfeldt M.L., and Zweier J.L. Evaluation of the role of polymorphonuclear leukocytes on contractile function in myocardial reperfusion injury. Circulation 87 (1993) 536-546
22. Takano H., Manchikalapudi S., Tang X.L., Qiu Y., Rizvi A., Jadoon A.K., Zhang Q., and Bolli R. Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. Circulation 98 (1998) 441-449
23. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc. Res. 61 (2004) 481-497
24. Waddick K.G., and Uckun F.M. Innovative treatment programs against cancer: II. Nuclear factor-kappa B as a molecular target. Biochem. Pharmacol. 57 (1999) 9-17
25. Wu A.H., and Lane P.L. Metaanalysis in clinical chemistry: validation of cardiac troponin T as a marker for ischemic heart diseases. Clin. Chem. 41 (1995) 1228-1233
26. Yi J.H., Huang X.P., Chen Y., Luo Z.Y., and Zhong C.C. Studies on the iridoid glucosides of the root of Lamiophlomis rotata (Benth.) Kudo., a medicinal plant in Tibet. Acta Pharm. Sin. 32 (1997) 360-362
27. Zhu J., Qiu Y., Wang Q., Zhu Y., Hu S., Zheng L., Wang L., and Zhang Y. Low dose cyclophosphamide rescues myocardial function from ischemia-reperfusion in rats. Eur. J. Cardiothorac. Surg. 34 (2008) 661-666
28. Zimmerman B.J., and Granger D.N. Reperfusion-induced leukocyte infi{ligature}ltration: role of elastase. Am. J. Physiol. 59 (1990) H390-394
29. Zingarelli B., Salzman A.L., and Szabo C. Genetic disruption of poly (ADP-Ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. Circ. Res. 83 (1998) 85-94
30. Zhou R., Xu Q., Zheng P., Yan L., Zheng J., and Dai G. Cardioprotective effect of fluvastatin on isoproterenol-induced myocardial infarction in rat. Eur. J. Pharmacol. 586 (2008) 244-250